During the past decade, CHUV; Departement d'Oncologie conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 8 clinical trials were completed, i.e. on average, 47.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHUV; Departement d'Oncologie" #1 sponsor was "Hoffmann-La Roche" with 15 trials, followed by "Centre Hospitalier Universitaire Vaudois" with 5 trials sponsored, "Swiss Group for Clinical Cancer Research" with 4 trials sponsored, "Iovance Biotherapeutics, Inc." with 2 trials sponsored and "Lymphoma Study Association" with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHUV; Departement d'Oncologie" #1 collaborator was "Amgen" with 1 trials as a collaborator and "European Mantle Cell Lymphoma Network" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "CHUV; Departement d'Oncologie" are "Non-Small Cell Lung Cancer" (4 trials), "Lung Cancer" (2 trials), "Malignant Melanoma" (2 trials), "Metastatic Melanoma" (2 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "CHUV; Departement d'Oncologie" in a lesser frequency.

Most popular intervention types in "CHUV; Departement d'Oncologie" are "Drug" (24 trials), "Biological" (5 trials), "Other" (2 trials), "Radiation" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (6 trials), "Placebo" (3 trials), "Carboplatin" (2 trials), "Cisplatin" (2 trials) and "Cyclophosphamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "CHUV; Departement d'Oncologie" are 25 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "CHUV; Departement d'Oncologie". undefined are not yet recruiting, 5 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in CHUV; Departement d'Oncologie, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in CHUV; Departement d'Oncologie, 9 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".